![Rui Avelar](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 2 M $ al 31/07/2026
Rui Avelar is currently Chief Medical Officer, Head-Research & Development at Evolus, Inc. since 2018.
Formerly, Dr. Avelar was Chief Medical Officer at AEON Biopharma Sub, Inc. from 2014 to 2018 and Chief Medical Officer at Allergan Medical Optics from 2011 to 2013.
Dr. Avelar earned a doctorate from the University of Toronto in 1989.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
EVOLUS, INC. 0,6 % | 17/04/2026 | 388.999 ( 0,6 % ) | 2 M $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| EVOLUS, INC. | Director Técnico/Científico/I+D | 01/01/2014 |
| Empresas | Cargo | Fin |
|---|---|---|
AEON Biopharma Sub, Inc.
 AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology Manufactures and wholesales pharmaceuticals | Director Técnico/Científico/I+D | 01/02/2018 |
Allergan Medical Optics | Director Técnico/Científico/I+D | 01/12/2013 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Evolus, Inc.
 Evolus, Inc. Pharmaceuticals: MajorHealth Technology Manufactures neurotoxins | Health Technology |
University of Toronto
 University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Allergan Medical Optics | Electronic Technology |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology Manufactures and wholesales pharmaceuticals | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
